Skye Bioscience, INC. PREM14A Filing

Ticker: SKYE · Form: PREM14A · Filed: Apr 6, 2026 · CIK: 0001516551

Sentiment: neutral

Filing Stats: 4,774 words · 19 min read · ~16 pages · Grade level 14.1 · Accepted 2026-04-06 16:15:31

Filing Documents

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 35 Executive Officers 38

Executive Compensation and Other Information

Executive Compensation and Other Information 40 Overview 40 Summary Compensation Table 41 Narrative Disclosure to Summary Compensation Table 41 Retirement Plan 45 Change in Control Benefits 46 Outstanding Equity Awards at Fiscal Year-end 47 Equity Compensation Plan Information 49 Pay Versus Performance 50 Compensation Actually Paid and Cumulative TSR of the Company 52 Compensation Actually Paid and Net Income 52 Policies and Practices Related to the Grant of Equity Grant Awards 53 Certain Relationships And Related Person Transactions 54 Director and Executive Officer Compensation 54 Employment Agreements 54 Indemnification Agreements 54 E quity Grants t o Executive Officers 54 2024 PIPE Financings 54 W arrant Amendment 55 Policies and Procedures for Related Party Transactions 55 Householding o f Proxy Materials 56 Stockholder Proposals 57 Adjournment of the Annual Meeting of Shareholders 58 Where You Can Find More Information 59

Forward Looking Statements

Forward Looking Statements 60 Annex A Certificate of Amendment to the Company's Articles of Incorporation A- 1 Table of Contents Proxy Statement for the Skye Bioscience, Inc. 2026 Annual Meeting of Stockholders To Be Held On The board of directors (the "Board of Directors" or "Board") of Skye Bioscience, Inc. (the "Company," "we," "us," and "our") is soliciting your proxy for use at the 2026 annual meeting of stockholders (the "Annual Meeting") to be held on , at 1000 a.m. , Pacific Time. The Annual Meeting will be a completely virtual meeting, which will be conducted via live webcast. You will be able to participate in the Annual Meeting online and submit your questions in advance or during the meeting. For instructions on how to participate in and vote your shares during the Annual Meeting, see the information in the accompanying Proxy Statement in the Section entitled, "General Information about the Annual Meeting and Voting – How can I participate in and vote at the Annual Meeting" We intend to mail proxy materials on or about to all stockholders of record entitled to vote at the Annual Meeting, including a Notice of Internet Availability of Proxy Materials (the "Notice") containing instructions on how to access our proxy statement and annual report online and how to vote online. If you receive such a Notice by mail, you will not receive a printed copy of the proxy materials unless you specifically request one. However, the Notice contains instructions on how to request to receive printed copies of the proxy materials and a proxy card by mail. Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be held on The accompanying proxy statement and our Annual Report on Form 10-K are available electronically at www.proxyvote.com. Skye Bioscience, Inc. 1 2026 Proxy Statement Table of Contents Important Information About the 2026 Annual Meeting of Stockholders and Voting The information provided i

View Full Filing

View this PREM14A filing on SEC EDGAR

View on Read The Filing